glp-1 meaning Can one drug do it all? Reviewing the expanding clinical universe of agonists Are GLP-1 weight-loss drugs quietly

G6PD is an inherited X-linked recessive condition caused by gene mutations

Becker KL, Ferguson RH, McConahey WM

Meyer A, Eskandari S, Grallath S et al (2006) AtGAT1, a High Affinity Transporter for -Aminobutyric Acid in Arabidopsis thaliana

Methods Study design Representatives of the companies Bristol-Myers Squibb, Novo Nordisk, Sanofi, Merck, Novartis, Boehringer Ingelheim and Takeda were contacted with the request to provide the event numbers of acute pancreatitis with the respective drug and non-incretin comparators as well as the corresponding number of patient-years of exposure (PYOs) for the approved GLP-1 receptor agonists exenatide twice daily, exenatide weekly, liraglutide and lixisenatide, as well as the DPP-4 inhibitors sitagliptin, saxagliptin, vildagliptin, alogliptin and linagliptin